PURPOSE: Mental health-related stigma affects people with mental disorders and their families. We aimed to investigate the experience of stigma among relatives of patients with schizophrenia in Belarus and formulate recommendations for anti-stigma interventions. METHODS: We conducted and thematically analysed 20 interviews with relatives of people diagnosed with schizophrenia. Experience of discrimination, strategies to cope with it, and requests for interventions were examined. RESULTS: A number of themes related to the experience of stigma in the public life of relatives of people with schizophrenia were elicited in relation to: (1) mental health care (difficulties in contacting mental health professionals; in getting appropriate information; lack of alternatives to hospital treatment; absence of appropriate long-term care services); (2) employment of people living with schizophrenia and (3) contact with the police. Analysis of the strategies used to overcome difficulties revealed resignation and passive acceptance, self-reliance, and emotional containment during crises. Despite the passivity and scepticism in expressing needs, participants suggested a number of interventions that could reduce the burden of stigma. CONCLUSIONS: With respect to the public domain of life, substantial stigma and discrimination perceived by families of people living with schizophrenia in Belarus is associated with structural issues of the country's mental health care system. To reduce the stigma-related burden, action must be taken to: (1) educate and support families and (2) deal with structural issues, by reorganising mental health services to better meet the needs of the families of people diagnosed with schizophrenia, and by including them in decision making at all levels.

Association for the Improvement of Mental Health Programmes Geneve Switzerland

Department of Medical Psychology and Psychotherapy Grodno State Medical University Grodno Belarus

Department of Social Psychiatry National Institute of Mental Health Topolová 748 250 67 Klecany Czech Republic

Institute of Psychiatry Psychology and Neuroscience King's College London London UK

See more in PubMed

Schizophr Bull. 2016 May;42(3):600-7 PubMed

Hosp Community Psychiatry. 1994 Oct;45(10):987-92 PubMed

Can J Psychiatry. 2014 Oct;59(10 Suppl 1):S19-26 PubMed

J Couns Psychol. 2013 Apr;60(2):311-6 PubMed

Eur Psychiatry. 2014 Aug;29(6):381-9 PubMed

Soc Sci Med. 2014 Feb;103:1-6 PubMed

Soc Sci Med. 2003 Jan;56(2):299-312 PubMed

Soc Psychiatry Psychiatr Epidemiol. 2016 May;51(5):757-65 PubMed

Soc Psychiatry Psychiatr Epidemiol. 2007 Jan;42(1):14-23 PubMed

Int Rev Psychiatry. 2007 Apr;19(2):137-55 PubMed

Med Educ. 2006 Apr;40(4):314-21 PubMed

Lancet. 2016 Apr 16;387(10028):1672-85 PubMed

PLoS One. 2012;7(6):e38490 PubMed

J Behav Health Serv Res. 2007 Apr;34(2):186-97 PubMed

Lancet. 2009 Jan 31;373(9661):408-15 PubMed

Br J Psychiatry. 2002 Dec;181:494-8 PubMed

BMC Health Serv Res. 2014 Jan 27;14:42 PubMed

Int J Group Psychother. 2011 Oct;61(4):577-95 PubMed

Lancet Psychiatry. 2014 Nov;1(6):467-82 PubMed

Lancet. 2007 Sep 29;370(9593):1164-74 PubMed

Epidemiol Psychiatr Sci. 2015 Oct;24(5):382-94 PubMed

Schizophr Bull. 1998;24(1):115-26 PubMed

Psychol Med. 2012 Aug;42(8):1741-52 PubMed

Int J Soc Psychiatry. 2014 Dec;60(8):733-40 PubMed

Schizophr Bull. 2011 Mar;37(2):381-8 PubMed

Acad Psychiatry. 2008 Mar-Apr;32(2):87-91 PubMed

Lancet. 2013 Jun 8;381(9882):1970-1 PubMed

Can J Psychiatry. 2014 Oct;59(10 Suppl 1):S13-8 PubMed

Soc Sci Med. 2007 Apr;64(7):1524-35 PubMed

Lancet Psychiatry. 2014 Aug;1(3):177-8 PubMed

Acta Psychiatr Scand Suppl. 2001;(410):89-95 PubMed

Psychiatry Res. 2004 Dec 30;129(3):257-65 PubMed

Schizophr Bull. 2004;30(3):481-91 PubMed

Br J Psychiatry. 1992 Feb;160:230-41; discussion 241-3 PubMed

Psychiatr Serv. 2012 Oct;63(10):963-73 PubMed

Soc Sci Med. 2014 Feb;103:84-93 PubMed

BMC Psychiatry. 2014 Apr 23;14:120 PubMed

Soc Psychiatry Psychiatr Epidemiol. 2003 Oct;38(10):593-602 PubMed